首页> 外文OA文献 >Desenvolvimento de formas farmacêuticas sólidas orais de Uncaria tomentosa com actividade antioxidante
【2h】

Desenvolvimento de formas farmacêuticas sólidas orais de Uncaria tomentosa com actividade antioxidante

机译:具有抗氧化活性的毛圆虫固体口服剂型的研制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Uncaria tomentosa is a plant widely used in Peru’s traditional medicine. Thedecoction of the vine is used traditionally for many different health problems.A decoction was made from the bark of Uncaria tomentosa.The phenolic profiles of decocto and bark were analysed using HPLC, with diode arraydetector. In both samples it was identified caffeic acid as the major constituent. It wasalso identified protocatechuic acid, catechin and epicatechin. There was also thepresence of a large number of compounds with characteristic profile of 3-flavanols,possibly proanthocyanidines.For comparative purposes aqueous dried extract, Uncaria tomentosa barks, andalso a commercial extract of this plant were monitored for their antioxidant properties,against DPPH. The lyophilised aqueous extract of Uncaria tomentosa barks was themore active. This was also the extract with a high content of proanthocyanidins,determined through the vanillin method. These results support previous studies thatsuggest the importance of proanthocyanidins in the extract antioxidant potential.Antioxidants play a significant role in the pathogenesis of many diseases. One ofthe goals of this study was to get a pharmaceutical form with both antioxidant activityand high proanthocyanidins content. Early studies in vitro demonstrated thatprocyanidin oligomers are hydrolysed to mixtures of monomers and dimers in gastricmilieu. Since the absorption of monomers and dimers in the small intestine it’s easierthan proanthocyanidins with high molecular weight, it seemed preferable to select apharmaceutical form of conventional release.The success of a pharmaceutical form depends on the careful selection of theexcipients used, because the incompatibility between a drug and its excipients canchange its stability and bioavailability, influencing its effectiveness and safety. In orderto select pharmaceutical forms were carried out compatibility studies between Uncariatomentosa extracts and different excipients using differential scanning calorimetry(DCS) and tests of dissolution in simulated gastric juice, at 37 ºC, with 100 revolutionsper minute. The results obtained allow to select two formulations of dried extractprepared in accordance with the traditional methodology: capsules containing aqueousdried extract and sprayed Uncaria tomentosa barks (50 mg and 336,7 mg, respectively),without any excipients; capsules with dried extract (100 mg) and the excipientsselected; corn starch 10%, lactose 20% and microcrystalline cellulose 10%. Theseformulations were in accordance with the requirements for quality: tests of mass trialsuniformity, and of content uniformity.Dissolution tests were also conducted with commercial extract (with starch as anexcipient) and a presentation form available on the market, containing only powederedbark, named uncária Naturmil®. All the formulations were within the parameters ofquality defined: at least 85% of drug released at first 60 minutes.In order to compare the antioxidant activity of pharmaceutical forms developedwith other already marketed, the DPPH test was optimised to the new experimentalconditions: samples solubilized in simulated gastric juice.The determination of antioxidant activity in all formulations suggests that thereis also in gastric juice, a relationship between the content in proantocianidinas andantioxidant activity, since the formulations with dried extract, evidencing increasinglevels of procyanidins had an antioxidant activity significantly higher than otherformulations.Taking into account the results obtained with a mixture of pulverized bark withdried extract, where the antioxidant activity in gastric juice decreases in a significantway, between 20 and 40 minutes, and the results from other studies which suggest thatthe antioxidant activity of higher molecular weight procyanidins is more effective thantheir monomeric procyanidins, it was also made a study in order to know the evolutionof polymerization degree of procyanidines, over time, by TLC. The results suggest thatthe mixture of dried extract and pulverized bark had lower molecular weightprocyanidins from 20 to 100 minutes, in simulated gastric fluid, which may be oneexplanation for its decrease in antioxidant activity over time.
机译:毛叶Uncaria tomentosa是一种广泛用于秘鲁传统医学中的植物。葡萄藤的汤剂传统上用于解决许多不同的健康问题,是用毛圆虫(Uncaria tomentosa)的树皮制成汤剂,并使用HPLC和二极管阵列检测器对decocto和树皮的酚类进行分析。在两个样品中,咖啡酸都是主要成分。还鉴定出原儿茶酸,儿茶素和表儿茶素。还存在大量具有3-黄烷醇特征性特征的化合物,可能是原花青素。为了比较目的,针对DPPH,监测了干提取物,毛白叶Uncaria tomentosa树皮以及市售提取物的抗氧化性能。毛叶Uncaria tomentosa树皮的冻干水提取物更具有活性。这也是通过香草醛法测定的高原花青素含量的提取物。这些结果支持了以前的研究,这些研究表明原花青素在提取物中具有抗氧化潜力。抗氧化剂在许多疾病的发病机理中起着重要作用。这项研究的目的之一是获得一种既具有抗氧化活性又具有高原花色素含量的药物形式。体外的早期研究表明,原花青素低聚物在胃液中被水解成单体和二聚体的混合物。由于小肠中单体和二聚体的吸收要比高分子量原花青素容易,因此选择常规释放形式的药物形式似乎更为可取。药物形式的成功取决于所用赋形剂的仔细选择,因为两者之间的不相容性药物及其赋形剂会改变其稳定性和生物利用度,从而影响其有效性和安全性。为了选择药物形式,使用差示扫描量热法(DCS)进行了钩藤提取物与不同赋形剂之间的相容性研究,并在37ºC下以每分钟100转的速度测试了在模拟胃液中的溶出度。所获得的结果允许选择按照传统方法制备的两种干燥提取物的配方:含有含水干燥提取物和喷雾的Uncaria tomentosa树皮的胶囊(分别为50 mg和336.7 mg),没有任何赋形剂;用干提取物(100毫克)和赋形剂选择的胶囊;玉米淀粉10%,乳糖20%,微晶纤维素10%。这些配方符合质量要求:大量试验的均一性和含量均一性测试。还使用市售提取物(以淀粉为辅料)和市场上出售的仅含粉末状树皮的展示形式进行了溶出度测试,命名为uncáriaNaturmil ®。所有制剂均符合定义的质量参数:在开始的60分钟内至少释放了85%的药物。为了比较已开发的药物形式与已上市的其他药物形式的抗氧化活性,将DPPH测试优化至新的实验条件:所有配方中抗氧化活性的测定表明,在胃液中也存在原花青素含量与抗氧化活性之间的关系,因为干燥提取物的配方表明原花青素含量不断增加,其抗氧化活性明显高于其他配方。考虑到将粉末状的树皮和干燥的提取物混合得到的结果,其中胃液中的抗氧化活性在20到40分钟之间显着降低,并且其他研究的结果表明较高分子量的原花青素具有抗氧化活性。它比其单体原花青素更有效,因此也进行了一项研究,以了解薄层色谱法随时间推移原花青素聚合度的变化。结果表明,在模拟胃液中,干提取物和粉碎的树皮的混合物在20至100分钟内具有较低的原花青素分子量,这可能是其抗氧化活性随时间降低的一个解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号